novartis glp-1 receptor agonist Glucagon-like peptide-1 agonists and muscle mass effects Liraglutide is a GLP-1 Receptor

Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: Exploring the subclinical psoriatic arthritis stage

those who received a medication that was not a GLP-1 receptor agonist

Psychological Impact of Weight Gain and Diet Fatigue Years of failed attempts often erode confidence and contribute to shame, anxiety, and social isolation

Risk of Major Adverse Cardiovascular Events and All-Cause Mortality under Treatment with Glp-1 Ras or the Dual Gip/Glp-1 Receptor Agonist Tirzepatide in Overweight or Obese Adults without Diabetes: A Systematic Review and Meta-Analysis

Only under medical supervision

First, it is important to set realistic timelines